Joseph Hernandez Net Worth

The estimated Net Worth of Joseph Hernandez is at least $7.26 Million dollars as of 2 December 2020. Joseph Hernandez owns over 5,000,000 units of Oragenics Inc stock worth over $2,100,000 and over the last 4 years Joseph sold OGEN stock worth over $5,158,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Joseph Hernandez OGEN stock SEC Form 4 insiders trading

Joseph has made over 2 trades of the Oragenics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Joseph sold 4,200,000 units of OGEN stock worth $3,108,000 on 4 January 2021.

The largest trade Joseph's ever made was selling 5,000,000 units of Oragenics Inc stock on 2 December 2020 worth over $2,050,000. On average, Joseph trades about 4,600,000 units every 17 days since 2020. As of 2 December 2020 Joseph still owns at least 4,200,000 units of Oragenics Inc stock.

You can see the complete history of Joseph Hernandez stock trades at the bottom of the page.

What's Joseph Hernandez's mailing address?

Joseph's mailing address filed with the SEC is 15 EAST PUTNAM AVENUE, SUITE 363, , GREENWICH, CT, 06830.

Insiders trading at Oragenics Inc

Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez, and Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.

What does Oragenics Inc do?

oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.

Complete history of Joseph Hernandez stock trades at Oragenics Inc

Oragenics Inc executives and stock owners

Oragenics Inc executives and other stock owners filed with the SEC include:

• Michael O. Sullivan CPA,
  CFO, Sec., Treasurer & Interim Principal Exec. Officer
• Dr. Martin Handfield M.Sc., Ph.D.,
  Sr. VP of Discovery Research
• Michael Sullivan,
  Chief Financial Officer, Treasurer, Secretary
• Dr. Frederick W. Telling Ph.D.,
  Exec. Chairman
• Charles Pope,
  Independent Director
• Robert Koski,
  Independent Director
• Alan Dunton,
  Independent Director
• Kim Murphy,
  Director
• Alan Joslyn,
  President, Chief Executive Officer, Director
• Frederick Telling,
  Independent Chairman of the Board
• Dr. Raman Bedi,
  Chairman of International Scientific Advisory Board and Sr. Consultant
• Joseph Hernandez,
  10% owner
• John P Gandolfo,
  Director
• Bruce A. Sr. Cassidy,
  Director
• Randal Jintrexon Corp Kirk,
  
• Fred Telling,
  Director
• Family Lpkoski Robert Ckosk...,
  
• Janet Huffman,
  CFO, Secretary and Treasurer
• Christine L Koski,
  
• Family Lp Koski,
  
• Thomas L Koski,
  
• Beverly Koski,
  
• Robert Ckoski Christine Lko...,
  
• Family Lpkoski Christine Lk...,
  
• John N Bonfiglio,
  President and CEO
• Family Lpkoski Beverlykoski...,
  
• J Michael Redmond,
  President
• Robert C Koski,
  Director